Inventor · disambiguated record
Gregory Alan Lazar
Also filed as: LAZAR GREGORY · LAZAR GREGORY A · LAZAR GREGORY ALAN
98 granted patents·92 pending applications·4,697 citations·filing 2003–2025
99Inventor score
Files withXENCOR INC120LAZAR GREGORY ALAN17GENENTECH INC11BERNETT MATTHEW J9CHAMBERLAIN AARON KEITH9
Top patents by PatentIndex Score
190 records- 0199US12466897B2Heterodimeric human IgG1 polypeptides with isoelectric point modificationsXENCOR INC·Filed 2025·Granted Nov 11, 2025·1 cites·1 claims
- 0299US8802820B2Fc variants with altered binding to FcRnCHAMBERLAIN AARON KEITH·Filed 2007·Granted Aug 12, 2014·83 cites·4 claims
- 0399US8367805B2Fc variants with altered binding to FcRnXENCOR INC·Filed 2008·Granted Feb 5, 2013·210 cites·3 claims
- 0499US8088376B2Fc variants with altered binding to FcRnCHAMBERLAIN AARON KEITH·Filed 2011·Granted Jan 3, 2012·191 cites·1 claims
- 0599US8039592B2Optimized Fc variants and methods for their generationXENCOR INC·Filed 2007·Granted Oct 18, 2011·86 cites·19 claims
- 0699US7662925B2Optimized Fc variants and methods for their generationXENCOR INC·Filed 2006·Granted Feb 16, 2010·349 cites·15 claims
- 0799US7317091B2Optimized Fc variantsXENCOR INC·Filed 2004·Granted Jan 8, 2008·872 cites·1 claims
- 0899US7276585B2Immunoglobulin variants outside the Fc regionXENCOR INC·Filed 2005·Granted Oct 2, 2007·197 cites·1 claims
- 0998US10584176B2Fc variants with increased affinity for FcγRIIcXENCOR INC·Filed 2018·Granted Mar 10, 2020·21 cites·10 claims
- 1098US10336818B2Fc variants with altered binding to FcRnXENCOR INC·Filed 2014·Granted Jul 2, 2019·47 cites·5 claims
- 1198US9803023B2Fc variants with altered binding to FcRnXENCOR INC·Filed 2015·Granted Oct 31, 2017·62 cites·9 claims
- 1298US9051373B2Optimized Fc variantsXENCOR INC·Filed 2013·Granted Jun 9, 2015·40 cites·4 claims
- 1398US8937158B2Fc variants with increased affinity for FcγRIIcLAZAR GREGORY ALAN·Filed 2007·Granted Jan 20, 2015·56 cites·8 claims
- 1498US8883973B2Fc variants with altered binding to FcRnCHAMBERLAIN AARON KEITH·Filed 2010·Granted Nov 11, 2014·57 cites·20 claims
- 1598US8735545B2Fc variants having increased affinity for fcyrllcLAZAR GREGORY ALAN·Filed 2007·Granted May 27, 2014·59 cites·9 claims
- 1698US8637641B2Antibodies with modified isoelectric pointsDAHIYAT BASSIL I·Filed 2011·Granted Jan 28, 2014·140 cites·6 claims
- 1798US8546543B2Fc variants that extend antibody half-lifeLAZAR GREGORY ALAN·Filed 2011·Granted Oct 1, 2013·60 cites·1 claims
- 1898US8394925B2Fc variants with altered binding to FcRnCHAMBERLAIN AARON KEITH·Filed 2011·Granted Mar 12, 2013·63 cites·4 claims
- 1998US8388955B2Fc variantsLAZAR GREGORY ALAN·Filed 2007·Granted Mar 5, 2013·104 cites·4 claims
- 2098US8383109B2Optimized Fc variants and methods for their generationXENCOR INC·Filed 2012·Granted Feb 26, 2013·40 cites·4 claims
- 2198US8362210B2Antibody variants with enhanced complement activityXENCOR INC·Filed 2011·Granted Jan 29, 2013·47 cites·10 claims
- 2298US8329867B2CTLA4-Ig immunoadhesinsLAZAR GREGORY A·Filed 2011·Granted Dec 11, 2012·106 cites·13 claims
- 2398US8188231B2Optimized FC variantsLAZAR GREGORY ALAN·Filed 2005·Granted May 29, 2012·188 cites·10 claims
- 2498US8124731B2Optimized Fc variants and methods for their generationLAZAR GREGORY ALAN·Filed 2007·Granted Feb 28, 2012·55 cites·4 claims
- 2598US8101720B2Immunoglobulin insertions, deletions and substitutionsLAZAR GREGORY A·Filed 2008·Granted Jan 24, 2012·174 cites·8 claims
- 2698US8093359B2Optimized Fc variants and methods for their generationLAZAR GREGORY ALAN·Filed 2007·Granted Jan 10, 2012·58 cites·19 claims
- 2798US8084582B2Optimized anti-CD20 monoclonal antibodies having Fc variantsDAHIYAT BASSIL I·Filed 2005·Granted Dec 27, 2011·115 cites·8 claims
- 2898US8063187B2Methods and compositions for inhibiting CD32B expressing cellsCHU SEUNG YUP·Filed 2008·Granted Nov 22, 2011·130 cites·2 claims
- 2998US7657380B2Methods of generating variant antibodies with increased host string contentXENCOR INC·Filed 2004·Granted Feb 2, 2010·169 cites·47 claims
- 3097US12492253B1Anti-human C5 antibodiesXENCOR INC·Filed 2025·Granted Dec 9, 2025·1 cites·1 claims
- 3197US10709766B2Fusion proteinsLILLY CO ELI·Filed 2017·Granted Jul 14, 2020·19 cites·13 claims
- 3297US10184000B2Optimized Fc variants and methods for their generationXENCOR INC·Filed 2016·Granted Jan 22, 2019·20 cites·38 claims
- 3397US9708406B2Anti-transferrin receptor antibodies and methods of useGENENTECH INC·Filed 2014·Granted Jul 18, 2017·87 cites·51 claims
- 3497US9605061B2Antibodies with modified isoelectric pointsXENCOR INC·Filed 2014·Granted Mar 28, 2017·43 cites·7 claims
- 3597US8753629B2Optimized Fc variantsLAZAR GREGORY ALAN·Filed 2013·Granted Jun 17, 2014·29 cites·26 claims
- 3697US8338574B2FC variants with altered binding to FCRNCHAMBERLAIN AARON KEITH·Filed 2010·Granted Dec 25, 2012·32 cites·5 claims
- 3797US8324351B2Fc variants with altered binding to FcRnCHAMBERLAIN AARON KEITH·Filed 2010·Granted Dec 4, 2012·30 cites·5 claims
- 3897US8093357B2Optimized Fc variants and methods for their generationLAZAR GREGORY ALAN·Filed 2006·Granted Jan 10, 2012·51 cites·3 claims
- 3996US11401348B2Heterodimeric Fc variantsXENCOR INC·Filed 2019·Granted Aug 2, 2022·10 cites·5 claims
- 4096US11254727B2CTLA4-Ig immunoadhesinsXENCOR INC·Filed 2021·Granted Feb 22, 2022·2 cites·4 claims
- 4196US9855318B2Fusion proteinsLILLY CO ELI·Filed 2016·Granted Jan 2, 2018·23 cites·4 claims
- 4296US9493578B2Compositions and methods for simultaneous bivalent and monovalent co-engagement of antigensLAZAR GREGORY A·Filed 2010·Granted Nov 15, 2016·28 cites·10 claims
- 4396US9353187B2Optimized FC variants and methods for their generationXENCOR INC·Filed 2013·Granted May 31, 2016·21 cites·9 claims
- 4496US9040041B2Modified FC moleculesDESJARLAIS JOHN R·Filed 2010·Granted May 26, 2015·35 cites·3 claims
- 4596US8858937B2Optimized Fc variants and methods for their generationXENCOR INC·Filed 2013·Granted Oct 14, 2014·20 cites·9 claims
- 4696US8802823B2Optimized Fc variantsXENCOR INC·Filed 2013·Granted Aug 12, 2014·24 cites·18 claims
- 4796US8551485B2Anti-CD40 antibodies and methods of inhibiting proliferation of CD40 expressing cellsBERNETT MATTHEW J·Filed 2009·Granted Oct 8, 2013·45 cites·27 claims
- 4896US8524867B2Optimized antibodies that target CD19BERNETT MATTHEW J·Filed 2007·Granted Sep 3, 2013·56 cites·32 claims
- 4996US8318907B2Fc variants with altered binding to FcRnCHAMBERLAIN AARON KEITH·Filed 2010·Granted Nov 27, 2012·27 cites·5 claims
- 5095US10183999B2Optimized Fc variants and methods for their generationXENCOR INC·Filed 2016·Granted Jan 22, 2019·10 cites·19 claims
Showing the top 50 of 190 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →